文献速递冠心病瓣膜病与结构性心脏病

首次急性心肌梗死后左心室血栓患者抗凝联合抗血小板治疗

Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
PubMed 文献 · Eur Heart J · 2018-01-01

本研究纳入2301例连续急性心肌梗死患者,分析其中1850例首次急性心肌梗死存活出院患者,92例(5.0%)合并左心室血栓。中位随访5.4年,左心室血栓组系统性栓塞发生率显著高于无血栓组。在84例使用维生素K拮抗剂的患者中,治疗范围时间(TTR)≥50%组栓塞事件发生率显著低于TTR<50%组,且大出血事件无差异。

要点

  • 首次急性心肌梗死合并左心室血栓患者系统性栓塞风险显著增高。
  • 左心室血栓是系统性栓塞的独立预测因素。
  • 维生素K拮抗剂TTR≥50%可降低栓塞事件且不增加大出血。

核心结论

  • 适当的抗凝治疗可能降低首次急性心肌梗死合并左心室血栓患者的栓塞事件发生率,且不增加出血事件。

研究设计与样本

  • 回顾性队列研究,纳入2001至2014年间2301例连续急性心肌梗死患者,分析其中1850例首次急性心肌梗死存活出院患者。
  • 左心室血栓通过超声心动图、左心室造影或心脏磁共振成像诊断,92例(5.0%)患者存在左心室血栓,年龄62±12岁。

主要发现

  • 中位随访5.4年(四分位距2.1-9.1年),左心室血栓组92例中15例(16.3%)发生系统性栓塞,无血栓组1758例中51例(2.9%)发生系统性栓塞。
  • Kaplan-Meier分析显示左心室血栓组系统性栓塞发生率显著更高(log-rank检验,P<0.001)。
  • 多因素分析显示左心室血栓是系统性栓塞的独立预测因素。
  • 在84例使用维生素K拮抗剂的左心室血栓患者中,TTR≥50%组(34例)仅1例发生栓塞事件,TTR<50%组(50例)9例发生栓塞事件(2.9% vs 19%,P=0.036)。
  • 大出血事件在TTR≥50%组与TTR<50%组之间无差异(9% vs 8%,P=0.89)。

临床怎么用

  • 对于首次急性心肌梗死合并左心室血栓的患者,应考虑抗凝联合抗血小板治疗,并维持维生素K拮抗剂TTR≥50%以降低栓塞风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: There are limited data about the optimal anti-thrombotic therapy for preventing embolism while minimizing bleeding events in patients with first acute myocardial infarction (AMI) complicated by left ventricular thrombus (LVT). METHODS AND RESULTS: Among 2301 consecutive patients with AMI hospitalized between 2001 and 2014, we studied 1850 patients with first AMI who discharged alive to investigate clinical characteristics, incidence of systemic embolism (SE), and association between anticoagulation and embolic or bleeding events. Left ventricular thrombus was diagnosed by echocardiography, left ventriculography, or cardiac magnetic resonance imaging in 92 (5.0%) patients (62 ± 12 years). During a median follow-up period of 5.4 years (interquartile range 2.1-9.1 years), SE occurred in 15 of 92 patients with LVT (16.3%) and 51 of 1758 patients without LVT (2.9%), respectively. Kaplan-Meier analysis showed a significantly higher incidence of SE in the LVT group (log-rank test, P < 0.001). Multivariate analysis showed that LVT was an independent predictor of SE. Among the LVT patients treated with vitamin K antagonists (n = 84), we compared the patients with therapeutic range (TTR) ≥50% (n = 34) and those with TTR <50% (n = 50). Only one embolic event developed in the TTR ≥50% group and nine embolic events developed in the TTR <50% group (2.9% vs. 19%, P = 0.036). There was no difference in major bleeding events (TTR ≥50%; 9% vs. TTR <50%; 8%, P = 0.89). CONCLUSION: Appropriate anticoagulation therapy may decrease the incidence of embolic events without increasing the incidence of bleeding events in patients with first AMI complicated by LV thrombus.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Maniwa N, Fujino M, Nakai M, et al. Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction. Eur Heart J. 2018. PMID: 29029233. doi:10.1093/eurheartj/ehx551

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。